The role of miR-19b in the inhibition of endothelial cell apoptosis and its relationship with coronary artery disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tang, Yong ^a   Zhang, Ya Chen ^a   Chen, Yu ^a   Xiang, Yin ^a   Shen, Cheng Xing ^a   Li, Yi Gang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 7; MICRORNA; MIRN19 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR NECROSIS FACTOR;

APOPTOSIS; BINDING SITE; BLOOD; CHEMISTRY; CORONARY ARTERY DISEASE; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MULTIGENE FAMILY; RNA INTERFERENCE; UMBILICAL VEIN ENDOTHELIAL CELL;

APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BINDING SITES; CASPASE 7; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; MULTIGENE FAMILY; PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84944128167     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15132     Document Type: Article

References (40)

1. Sullivan, K. E. et al. Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol 27, 5147-5160 (2007).
2. Kleinbongard, P., Heusch, G., Schulz, R. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127, 295-314 (2010).
3. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem J 326(Pt 1), 1-16 (1997).
4. Bushati, N., Cohen, S. M. microRNA functions. Annu Rev Cell Dev Biol 23, 175-205 (2007).
5. Adams, B. D., Kasinski, A. L., Slack, F. J. Aberrant regulation and function of microRNAs in cancer. Curr Biol 24, R762-R776 (2014).
6. Cheng, C., Wang, Q., You, W., Chen, M., Xia, J. MiRNAs as biomarkers of myocardial infarction: a meta-analysis. PLoS One 9, e88566 (2014).
7. Liebetrau, C. et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J Am Coll Cardiol 62, 992-998 (2013).
8. Fichtlscherer, S. et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 107, 677-684 (2010).
9. Mogilyansky, E., Rigoutsos, I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ 20, 1603-1614 (2013).
10. Olive, V., Li, Q., He, L. mir-17-92: a polycistronic oncomir with pleiotropic functions. Immunol Rev 253, 158-166 (2013).
11. Olive, V. et al. A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. Elife 2, e822 (2013).
12. Pickering, M. T., Stadler, B. M., Kowalik, T. F. miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 28, 140-145 (2009).
13. Bonauer, A. et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710-1713 (2009).
14. Doebele, C. et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 115, 4944-4950 (2010).
15. Takeda, K. et al. BDNF protects human vascular endothelial cells from TNFalpha-induced apoptosis. Biochem Cell Biol 91, 341-349 (2013).
16. Huang, J., Kontos, C. D. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 277, 10760-10766 (2002).
17. Li, X. et al. Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation. Phytother Res 28, 1553-1560 (2014).
18. Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T., Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105, 1516-1521 (2008).
19. Oudit, G. Y. et al. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37, 449-471 (2004).
20. Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489 (1997).
21. Kim, H. E., Du, F., Fang, M., Wang, X. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci USA 102, 17545-17550 (2005).
22. Brown, M. F. et al. Loss of Caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis. Cell Death Dis 6, e1729 (2015).
23. Zhang, J., Patel, J. M., Li, Y. D., Block, E. R. Proinflammatory cytokines downregulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells. Res Commun Mol Pathol Pharmacol 96, 71-87 (1997).
24. Dela, P. N., Simeonidis, S., Leo, C., Rose, D. W., Collins, T. Regulation of NF-kappaB-dependent gene expression by the POU domain transcription factor Oct-1. J Biol Chem 282, 8424-8434 (2007).
25. Rimbach, G., Valacchi, G., Canali, R., Virgili, F. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun 3, 238-242 (2000).
26. Pilbrow, A. P. et al. Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromes. Int J Cardiol 176, 375-385 (2014).
27. Wu, J. et al. Identification of serum microRNAs for cardiovascular risk stratification in dyslipidemia subjects. Int J Cardiol 172, 232-234 (2014).
28. Corsten, M. F. et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3, 499-506 (2010).
29. Kuwabara, Y. et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 4, 446-454 (2011).
30. Tijsen, A. J. et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res 106, 1035-1039 (2010).
31. Creemers, E. E., Tijsen, A. J., Pinto, Y. M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110, 483-495 (2012).
32. Liu, M. et al. TNF-alpha is a novel target of miR-19a. Int J Oncol 38, 1013-1022 (2011).
33. Ohira, T. et al. miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells. Scientific Reports 5, 8201 (2015).
34. Olive, V. et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23, 2839-2849 (2009).
35. Mu, P. et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23, 2806-2811 (2009).
36. Loyer, X. et al. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res 114, 434-443 (2014).
37. van Almen, G. C. et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell 10, 769-779 (2011).
38. Chhabra, R., Adlakha, Y. K., Hariharan, M., Scaria, V., Saini, N. Upregulation of miR-23a-27a-24-2 cluster induces caspasedependent and-independent apoptosis in human embryonic kidney cells. PLoS One 4, e5848 (2009).
39. Ruan, W., Xu, J. M., Li, S. B., Yuan, L. Q., Dai, R. P. Effects of down-regulation of microRNA-23a on TNF-alpha-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc Res 93, 623-632 (2012).
40. Jaffe, E. A., Nachman, R. L., Becker, C. G., Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52, 2745-2756 (1973).